Developer docs
API playgroundTry for free, no card

Search company profiles

Activ Surgical

Full company profile

uuid0000j5g

Namestring
Activ Surgical
Legal namestring
Activ Surgical Inc.
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Activ Surgical is a Boston-based digital surgery company founded in 2017 that develops intraoperative imaging and AI-powered visualization technology for minimally invasive and robotic surgery. Its flagship product, ActivSight Intelligent Light, is an FDA 510(k)-cleared (April 2021) and CE-marked (December 2022) modular imaging module that attaches to existing laparoscopic and robotic surgical systems, enabling surgeons to view tissue perfusion and critical anatomy in real time. The company targets major hospital networks across the U.S., Europe, and the Middle East through a subscription-based commercial model requiring no capital purchase, with named clinical and commercial customers including Ohio State Wexner Medical Center, UPMC, Memorial Hermann-Texas, Maastricht UMC, University of Cologne, and Abdali Hospital in Jordan.

The technology stack is built on the ActivEdge platform, which integrates Augmented Reality (AR), Artificial Intelligence (AI), and Machine Learning (ML) with proprietary sensing modalities. ActivSight supports two visualization modes: ActivPerfusion, a dye-free Laser Speckle Contrast Imaging (LSCI) mode that detects microvascular blood flow without fluorescent contrast agents, and ActivICG, which uses near-infrared fluorescence with indocyanine green (ICG) for bile duct and critical structure visualization. The upcoming ActivInsights AR software suite is intended to deliver AI-driven real-time tissue assessment as visual overlays, including a Colorectal AI Mode that isolates perfusion display to targeted tissue. The company holds four core U.S. patents and 30+ global patents, and clinical data demonstrate that ActivSight visualization changed intraoperative surgical decisions in 17.5% of minimally invasive left-sided colorectal cases.

Activ Surgical has raised approximately $92 million in total venture funding across Series A and Series B rounds, with key investors including Cota Capital (Series B lead), Hikma Ventures (Series B extension lead), NVIDIA (strategic technology partner), and GreatPoint Ventures. Revenue is generated through multi-year subscription fees for the ActivSight hardware/software bundle and proprietary AI-enabled software modes. Clinical validation through peer-reviewed publications, conference presentations at ASCRS, EAES, SAGES, and ACS, and surgeon testimonials serve as the primary demand-generation channels, with enterprise field sales closing multi-year contracts at the hospital-system level.

Short descriptiontext

Activ Surgical develops ActivSight, an FDA-cleared, CE-marked modular imaging module for laparoscopic and robotic surgery that provides real-time, AI-enhanced intraoperative visualization. The Boston-based company sells to major hospital networks across the U.S., Europe, and the Middle East via a subscription model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical imaging hardware, intraoperative visualization software, augmented reality surgery, medical AI imaging, minimally invasive surgery
Industry4 codes
PRIMARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Surgical Visualization and Intraoperative Imaging
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1ActivSight Hardware and Subscription
TypeSubscription Recurring
Description

ActivSight is sold as a modular hardware imaging module with a subscription-based cost of ownership model requiring no capital purchase. The device seamlessly attaches to existing laparoscopic and robotic systems, with revenue derived from hardware deployment and ongoing subscription fees for software-enabled advanced visualization capabilities.

activsurgical.com
2AI-Enabled Software Modes
TypeSubscription Recurring
Description

Activ Surgical generates revenue through proprietary AI software modes (such as Colorectal AI Mode) deployed within the ActivSight platform, delivered as part of the subscription or as additional software capabilities on the ActivEdge platform.

activsurgical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Pricing details1 tier
1Subscription-based access to ActivSight imaging module with no upfront capital purchase required.
ModelSubscriptionBilling cadenceMulti-year contract
Notes

ActivSight requires no capital purchase, with a subscription based cost of ownership. Specific pricing tiers and rates are not publicly disclosed.

activsurgical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1ActivEdge
Description

The platform that powers surgical innovation, leveraging AR, AI, ML and sensing-based technologies.

activsurgical.com
+7 more records
Core offering1 text field

Activ Surgical develops and sells the ActivSight Intelligent Light, a modular imaging module that attaches to existing laparoscopic and robotic surgical systems to provide surgeons with real-time intraoperative visual insights. The device supports dye-free perfusion visualization via Laser Speckle Contrast Imaging (LSCI) and ICG fluorescence modes with augmented reality overlays, sold under a subscription model with no upfront capital purchase required.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • In 17.5% of minimally invasive left-sided colorectal cases, surgeons changed an intraoperative decision based on additional information provided by ActivSight's advanced visualization.
+4 more records
Product and service3 records
1ActivSight Intelligent Light
CategorySurgical Visualization Hardware
Description

Flagship FDA-cleared and CE-marked modular imaging module that attaches to existing laparoscopic and robotic surgical systems, providing surgeons with real-time, on-demand intraoperative visual insights via augmented reality overlays. It is the first and only modular form-factor with multimodal Advanced Visualization for minimally invasive surgery, combining dye-free ActivPerfusion (LSCI) and ActivICG (ICG fluorescence) modes. Sold under a subscription-based cost of ownership model with no capital purchase required.

2ActivEdge Platform
CategorySoftware Platform
Description

The foundational software platform that powers Activ Surgical's surgical innovation by leveraging AR, AI, ML, and sensing-based technologies to enable surgeons to view critical physiological structures and functions that cannot be seen with the naked eye. ActivSight serves as the 'eyes' of the ActivEdge platform.

3ActivInsights Augmented Reality Software Suite
CategoryAugmented Reality Software
Description

Augmented Reality software suite powered by the ActivEdge platform that provides real-time tissue assessment in the form of visual overlays, designed to give surgeons intelligent information during procedures. Includes AI-driven perfusion insights and specialty modes such as colorectal AI that isolates perfusion display to targeted tissue.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Abdali Hospital, a member of the Clemenceau Network affiliated with Johns Hopkins Medicine International, completed the first international ActivSight procedure on December 24, 2023. This partnership represents Activ Surgical's first commercial use outside the U.S. and Europe, expanding into the Middle East.

Strategic tierStrategicTypeTechnology or Integration
Description

Activ Surgical selected NVIDIA Clara Holoscan running on the NVIDIA IGX platform to accelerate development of its AI and AR solution for real-time surgical guidance. NVIDIA provides edge AI computing infrastructure optimized for medical device applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Stryker acquired Novadaq Technologies (SPY-PHI fluorescence imaging) and offers ICG-based surgical visualization across multiple specialties. It is the closest direct competitor in intraoperative perfusion imaging and has far greater installed-base reach.

TypeBroad incumbent
Description

Da Vinci platform leader in robotic-assisted surgery and an Activ Surgical integration target. Intuitive's push into integrated AI visualization (e.g., Iris) represents both a partner opportunity and a long-term competitive threat to bolt-on platforms.

TypeDirect peer
Description

Major surgical endoscopy and visualization systems provider whose laparoscopic platforms and ICG/NIR fluorescence modules overlap directly with ActivSight's intended integration points in minimally invasive ORs.

TypeBroad incumbent
Description

CEO Manisha Shah-Bugaj's former employer and a leading surgical endoscopy and visualization player. Olympus VISERA and related platforms overlap with Activ Surgical's hardware-agnostic positioning in laparoscopic visualization.

TypeBroad incumbent
Description

Hugo robotic-assisted surgery platform with integrated ICG fluorescence and visualization. Medtronic competes both as a robotic platform Activ Surgical integrates with and as a broad medtech incumbent embedding AI features natively.

TypeDirect peer
Description

Surgical robotics company adding machine vision and AI-driven intraoperative guidance to its Senhance platform — directly comparable to Activ Surgical's computer-vision-plus-AR approach to surgical intelligence.

TypeEmerging player
Description

Neurosurgery-focused surgical visualization and AI company whose Modus V and BrightMatter platforms overlap with Activ Surgical's intraoperative imaging and AI-driven surgical guidance roadmap.

TypeBroad incumbent
Description

Surgical navigation, planning, and augmented-reality visualization platform used in neurosurgery, spine, ENT, and beyond — comparable to Activ Surgical's ActivEdge AR platform ambition and intraoperative visualization pipeline.

TypeEmerging player
Description

AR/VR surgical visualization company whose 360° visualization and preoperative planning tools overlap with Activ Surgical's ActivInsights AR suite focus on intraoperative visual overlays.

TypeEmerging player
Description

China-based laparoscopic robotic surgery company and an investor in Activ Surgical's 2022 Series B extension. Comparable as an emerging surgical robotics platform exploring modular visualization partnerships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors20 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Activ Surgical

Surgical Visualization and Intraoperative Imagingactivsurgical.com

Activ Surgical develops ActivSight, an FDA-cleared, CE-marked modular imaging module for laparoscopic and robotic surgery that provides real-time, AI-enhanced intraoperative visualization. The Boston-based company sells to major hospital networks across the U.S., Europe, and the Middle East via a subscription model.

What Activ Surgical does

Activ Surgical is a Boston-based digital surgery company founded in 2017 that develops intraoperative imaging and AI-powered visualization technology for minimally invasive and robotic surgery. Its flagship product, ActivSight Intelligent Light, is an FDA 510(k)-cleared (April 2021) and CE-marked (December 2022) modular imaging module that attaches to existing laparoscopic and robotic surgical systems, enabling surgeons to view tissue perfusion and critical anatomy in real time. The company targets major hospital networks across the U.S., Europe, and the Middle East through a subscription-based commercial model requiring no capital purchase, with named clinical and commercial customers including Ohio State Wexner Medical Center, UPMC, Memorial Hermann-Texas, Maastricht UMC, University of Cologne, and Abdali Hospital in Jordan.

The technology stack is built on the ActivEdge platform, which integrates Augmented Reality (AR), Artificial Intelligence (AI), and Machine Learning (ML) with proprietary sensing modalities. ActivSight supports two visualization modes: ActivPerfusion, a dye-free Laser Speckle Contrast Imaging (LSCI) mode that detects microvascular blood flow without fluorescent contrast agents, and ActivICG, which uses near-infrared fluorescence with indocyanine green (ICG) for bile duct and critical structure visualization. The upcoming ActivInsights AR software suite is intended to deliver AI-driven real-time tissue assessment as visual overlays, including a Colorectal AI Mode that isolates perfusion display to targeted tissue. The company holds four core U.S. patents and 30+ global patents, and clinical data demonstrate that ActivSight visualization changed intraoperative surgical decisions in 17.5% of minimally invasive left-sided colorectal cases.

Activ Surgical has raised approximately $92 million in total venture funding across Series A and Series B rounds, with key investors including Cota Capital (Series B lead), Hikma Ventures (Series B extension lead), NVIDIA (strategic technology partner), and GreatPoint Ventures. Revenue is generated through multi-year subscription fees for the ActivSight hardware/software bundle and proprietary AI-enabled software modes. Clinical validation through peer-reviewed publications, conference presentations at ASCRS, EAES, SAGES, and ACS, and surgeon testimonials serve as the primary demand-generation channels, with enterprise field sales closing multi-year contracts at the hospital-system level.

Activ Surgical firmographics

Firmographics
Name
Activ Surgical
Legal name
Activ Surgical Inc.
Website
https://activsurgical.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Activ Surgical develops ActivSight, an FDA-cleared, CE-marked modular imaging module for laparoscopic and robotic surgery that provides real-time, AI-enhanced intraoperative visualization. The Boston-based company sells to major hospital networks across the U.S., Europe, and the Middle East via a subscription model.
Ownership category
akta.pro rank

Activ Surgical industry classification

Industry
Product category
Surgical Visualization and Intraoperative Imaging
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Surgical imaging hardware
  • Intraoperative visualization software
  • Augmented reality surgery
  • Medical AI imaging
  • Minimally invasive surgery

Where Activ Surgical is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Activ Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. ActivSight Hardware and Subscription: ActivSight is sold as a modular hardware imaging module with a subscription-based cost of ownership model requiring no capital purchase. The device seamlessly attaches to existing laparoscopic and robotic systems, with revenue derived from hardware deployment and ongoing subscription fees for software-enabled advanced visualization capabilities.
  2. AI-Enabled Software Modes: Activ Surgical generates revenue through proprietary AI software modes (such as Colorectal AI Mode) deployed within the ActivSight platform, delivered as part of the subscription or as additional software capabilities on the ActivEdge platform.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractSubscription-based access to ActivSight imaging module with no upfront capital purchase required.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Activ Surgical product offering

Product offering

Core offering

Activ Surgical develops and sells the ActivSight Intelligent Light, a modular imaging module that attaches to existing laparoscopic and robotic surgical systems to provide surgeons with real-time intraoperative visual insights. The device supports dye-free perfusion visualization via Laser Speckle Contrast Imaging (LSCI) and ICG fluorescence modes with augmented reality overlays, sold under a subscription model with no upfront capital purchase required.

Differentiator

Problem solved

Functional benefit

Brands

  • ActivEdge: The platform that powers surgical innovation, leveraging AR, AI, ML and sensing-based technologies.
  • ActivSight
  • ActivInsights
  • ActivAssist
  • ActivPilot
  • ActivCare
  • ActivPerfusion
  • ActivICG

Products and services

  • ActivSight Intelligent Light Flagship FDA-cleared and CE-marked modular imaging module that attaches to existing laparoscopic and robotic surgical systems, providing surgeons with real-time, on-demand intraoperative visual insights via augmented reality overlays. It is the first and only modular form-factor with multimodal Advanced Visualization for minimally invasive surgery, combining dye-free ActivPerfusion (LSCI) and ActivICG (ICG fluorescence) modes. Sold under a subscription-based cost of ownership model with no capital purchase required.
  • ActivEdge Platform The foundational software platform that powers Activ Surgical's surgical innovation by leveraging AR, AI, ML, and sensing-based technologies to enable surgeons to view critical physiological structures and functions that cannot be seen with the naked eye. ActivSight serves as the 'eyes' of the ActivEdge platform.
  • ActivInsights Augmented Reality Software Suite Augmented Reality software suite powered by the ActivEdge platform that provides real-time tissue assessment in the form of visual overlays, designed to give surgeons intelligent information during procedures. Includes AI-driven perfusion insights and specialty modes such as colorectal AI that isolates perfusion display to targeted tissue.

Quantifiable outcome

  • In 17.5% of minimally invasive left-sided colorectal cases, surgeons changed an intraoperative decision based on additional information provided by ActivSight's advanced visualization.
  • +4 more outcomes

Companies that use Activ Surgical

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Activ Surgical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature5 records

Activ Surgical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered strategic.

  • Abdali Hospital (Clemenceau Network)strategicStrategic or Co-development PartnerAbdali Hospital, a member of the Clemenceau Network affiliated with Johns Hopkins Medicine International, completed the first international ActivSight procedure on December 24, 2023. This partnership represents Activ Surgical's first commercial use outside the U.S. and Europe, expanding into the Middle East.
  • NVIDIA (Technology Partnership)strategicTechnology or IntegrationActiv Surgical selected NVIDIA Clara Holoscan running on the NVIDIA IGX platform to accelerate development of its AI and AR solution for real-time surgical guidance. NVIDIA provides edge AI computing infrastructure optimized for medical device applications.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Activ Surgical competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Stryker acquired Novadaq Technologies (SPY-PHI fluorescence imaging) and offers ICG-based surgical visualization across multiple specialties. It is the closest direct competitor in intraoperative perfusion imaging and has far greater installed-base reach.
  • Intuitive Surgical: Da Vinci platform leader in robotic-assisted surgery and an Activ Surgical integration target. Intuitive's push into integrated AI visualization (e.g., Iris) represents both a partner opportunity and a long-term competitive threat to bolt-on platforms.
  • Olympus: CEO Manisha Shah-Bugaj's former employer and a leading surgical endoscopy and visualization player. Olympus VISERA and related platforms overlap with Activ Surgical's hardware-agnostic positioning in laparoscopic visualization.
  • Medtronic: Hugo robotic-assisted surgery platform with integrated ICG fluorescence and visualization. Medtronic competes both as a robotic platform Activ Surgical integrates with and as a broad medtech incumbent embedding AI features natively.
  • Brainlab: Surgical navigation, planning, and augmented-reality visualization platform used in neurosurgery, spine, ENT, and beyond — comparable to Activ Surgical's ActivEdge AR platform ambition and intraoperative visualization pipeline.

Direct peers

  • KARL STORZ: Major surgical endoscopy and visualization systems provider whose laparoscopic platforms and ICG/NIR fluorescence modules overlap directly with ActivSight's intended integration points in minimally invasive ORs.
  • Asensus Surgical: Surgical robotics company adding machine vision and AI-driven intraoperative guidance to its Senhance platform — directly comparable to Activ Surgical's computer-vision-plus-AR approach to surgical intelligence.

Emerging players

  • Synaptive Medical: Neurosurgery-focused surgical visualization and AI company whose Modus V and BrightMatter platforms overlap with Activ Surgical's intraoperative imaging and AI-driven surgical guidance roadmap.
  • Surgical Theater: AR/VR surgical visualization company whose 360° visualization and preoperative planning tools overlap with Activ Surgical's ActivInsights AR suite focus on intraoperative visual overlays.
  • Ronovo Surgical: China-based laparoscopic robotic surgery company and an investor in Activ Surgical's 2022 Series B extension. Comparable as an emerging surgical robotics platform exploring modular visualization partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Activ Surgical social profiles

Digital presence

Activ Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Activ Surgical leadership team

Management profile

Number of profiles

Profiles4 records

Activ Surgical funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors20 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Activ Surgical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Activ Surgical

What does Activ Surgical do?

Activ Surgical develops and sells the ActivSight Intelligent Light, a modular imaging module that attaches to existing laparoscopic and robotic surgical systems to provide surgeons with real-time intraoperative visual insights. The device supports dye-free perfusion visualization via Laser Speckle Contrast Imaging (LSCI) and ICG fluorescence modes with augmented reality overlays, sold under a subscription model with no upfront capital purchase required.

Is Activ Surgical a public or private company?

Activ Surgical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Activ Surgical founded?

Activ Surgical was founded in 2017. It employs 11 to 50 people.

Where is Activ Surgical based?

Activ Surgical is headquartered in Boston, United States, in the North America region.

How does Activ Surgical make money?

Two revenue lines are on record. ActivSight Hardware and Subscription is the primary driver. The others are AI-Enabled Software Modes.

Who are Activ Surgical's main competitors?

Broad incumbents on record are Stryker, Intuitive Surgical, Olympus, Medtronic and Brainlab. Direct peers are KARL STORZ and Asensus Surgical. Emerging players are Synaptive Medical, Surgical Theater and Ronovo Surgical.

Does Activ Surgical have an API?

No public API is recorded for Activ Surgical.

What industry is Activ Surgical in?

Activ Surgical's product category is Surgical Visualization and Intraoperative Imaging. Its primary akta.pro industry code is HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence), with a secondary code of HLAHADAD, Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
F6s100 Top Medical Equipment Companies in United States · December 2025The article presents a curated list of 100 top medical equipment companies and startups in the United States as of December 2025, powered by the F6S community. It highlights specific firms such as Levita Magnetics, Koya Medical, and Activ Surgical, detailing their innovative products in areas like robotic surgery, venous care, and AI-augmented platforms. The content serves as an industry directory showcasing recent developments and funding activities within the US medical technology sector.AETOSWireActiv Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight™ Intelligent Light at Abdali Hospital in JordanActiv Surgical completed its first international surgery using ActivSight at Abdali Hospital in Amman, Jordan. The procedure was a bariatric revision performed by Dr. Mohamad Rassoul Abu-Nuwar, with ActivSight's ActivPerfusion mode providing real-time tissue perfusion visualization. Hikma Ventures, the company's investor, highlighted the milestone as part of its commitment to advancing surgical technology in the MENA region.Business Wire BlogActiv Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent LightActiv Surgical completed its first international surgery at Abdali Hospital in Amman, Jordan, on December 24, 2023, using its ActivSight device. The procedure was a bariatric revision performed by Dr. Mohamad Rassoul Abu-Nuwar, with support from Hikma Ventures. The company plans additional customer sites in 2024.TherobotreportActiv Surgical completes first case with ActivSightActiv Surgical completed its first case with ActivSight Intelligent Light on December 22, 2022, at Ohio State University Wexner Medical Center. The laparoscopic left colectomy used the colorectal AI mode, which isolated perfusion visualization to the colon. The company is now conducting a clinical study to evaluate the system's utility.MassDeviceActiv Surgical completes first AI-enabled case with ActivSight intelligent lightActiv Surgical completed its first AI-enabled surgical case using the ActivSight Intelligent Light product. The surgery, performed by Dr. Matthew Kalady at The Ohio State University Wexner Medical Center, utilized advanced visualization and AI technology to enhance real-time surgical insights. This marks a significant step towards improving surgical safety and patient care through innovative technology.FierceBiotechMinerva Surgical taps outgoing Activ Surgical head Usen for CEOTodd Usen, former Activ Surgical CEO, became president and CEO of Minerva Surgical, effective this week. Minerva develops minimally invasive devices for abnormal uterine bleeding, and outgoing CEO David Clapper will stay on for 12 months as a consultant. Usen brings over three decades of medtech experience.FierceBiotechActiv Surgical taps another Olympus alum as CEO, replacing inaugural leader UsenActiv Surgical appointed Manisha Shah-Bugaj as CEO, replacing Todd Usen, who will remain on the board. Shah-Bugaj, formerly COO, will lead the global launch of ActivSight Intelligent Light, an FDA-cleared augmented reality surgical tool. The company has raised $60 million in funding.Built In BostonActiv Surgical Pulls in Additional $15M, Bringing Series B Total to $60MActiv Surgical secured an additional $15 million in funding as an extension to its Series B round, bringing the total Series B investment to $60 million and the company's cumulative funding to $92 million. The extension, led by Hikma Ventures, will support the commercial launch of its AI-powered ActivSight imaging module in 2022 and subsequent hiring efforts. This capital injection follows recent FDA clearance for the device, which aims to enhance surgical safety by visualizing microscopic tissue details.PR NewswireHikma Ventures leads Series B extension in Activ Surgical to support the global commercialization of its platformHikma Pharmaceuticals PLC announced that its venture capital arm, Hikma Ventures, led a $15 million USD extension of Activ Surgical's Series B financing round to support the commercialization of its ActivSight imaging module. This brings the total amount raised in the Series B round to $60 million USD and aims to enhance surgical decision-making through augmented reality and AI technologies. The investment will facilitate Activ Surgical's global launch of its product, enhancing surgical care and patient safety.MassDeviceActiv Surgical raises $15M in Series B extensionActiv Surgical received a $15 million extension to its Series B funding round, led by Hikma Ventures, bringing the total Series B to $60 million. The company develops AR and AI-driven surgery technology, with its ActivSight imaging module receiving FDA clearance and being prepared for a global launch in 2022.